1[1]Mayer NH, Esquenazi A, Childress MK. Common patterns of clinical motor dysfunction[J]. Muscle Nerve, 1997,56: S21-35.
2[2]Esquenazi A, Mayer NH, Keenan MA. Dynamic polyelectromyography, neurolysis and chemodenervation with Btulium Toxin A for assessment and treatment of gait dysfunction[J]. In Ruzicka E, Hallett M and Jankovic J. ed. Gait Disorders. Advances in Neurology. Lippincott Williams & Wilkins, Philadelphia, 2001,87: 321-332.
3[3]Brin MF. Dosing, administration, and a treatment algorithm for use of Botulinum Toxin A for adult-onset spasticity[J]. Muscle and Nerve, 1997,Suppl 6: 214.
4[4]On AY , Kirazli Y , Kismali B, et al. Mechanisms of action of phenol block and botulinus toxin Type A in relieving spasticity: electrophysiologic investigation and follow-up[J]. Am J Phys Med Rehabil, 1997, 78(4): 344-349.
5[5]Keenan MA, Mayer NH, Esquenazi A, et al. A neuroorthopedic approach to the management of common patterns of upper motor neuron dysfunction after brain injury[J]. Neurol Rehabil, 1999,12:119-143.
6[6]Esquenazi A, Keenan MA. Gait analysis: in DeLisa JA, Gans BM, eds. Rehabilitation Medicine: principles and practice[M]. 2nd ed. Philadelphia: J. B. Lippincott,1993.122-130.
7[7]Esquenazi A, Talaty M. Gait analysis, technology and clinical applications. In: Braddom R, ed. Physical Medicine and Rehabilitation[M]. 2nd ed. Philadelphia: W.B. Saunders, 2000.93-108.
8[8]Chua KS, Kong KH. Clinical and functional outcome after alcohol neurolysis of the tibial nerve for ankle-foot spasticity[J]. Brain Inj, 2001,15(8): 733-739.
9[9]Chua KS, Kong KH. Alcohol neurolysis of the sciatic nerve in the treatment of hemiplegic knee flexor spasticity: clinical outcomes[J]. Arch Phys Med Rehabil, 2000,81(10): 1432-1435.
